Pronóstico del mercado de bioprocesamiento de Asia Pacífico hasta 2031: análisis regional, por producto (instrumentos, consumibles y accesorios), escala de operación (operaciones comerciales y operaciones clínicas), proceso (bioproceso descendente y bioproceso ascendente), aplicación (anticuerpos monoclonales, vacunas, proteínas recombinantes, terapia celular y génica, y otros) y usuario final (compañías biofarmacéuticas, organizaciones de fabricación por contrato y otros)
La creciente demanda de medicina personalizada impulsa el mercado de bioprocesamiento de Asia Pacífico
La transformación de la industria de la salud de un enfoque único a un enfoque específico está expandiendo la demanda de medicina personalizada. La medicina de precisión se considera uno de los enfoques más prometedores para abordar problemas de salud como el cáncer, las enfermedades neurodegenerativas y las enfermedades genéticas raras. Es probable que las innovaciones en la producción de medicamentos personalizados afecten a todo el sector, y las tecnologías de un solo uso destinadas a la producción de menor volumen tienen aplicaciones potenciales en la bioproducción de proteínas, particularmente en procesos posteriores. Los enfoques personalizados y diferenciados de la medicina están generando la necesidad de una gama más amplia de productos, muchos de ellos para un grupo relativamente pequeño de pacientes. Por lo tanto, puede ser necesario un enfoque fundamentalmente diferente para la producción y distribución de productos biológicos. La medicina de precisión utiliza la información genómica de un individuo para ofrecer un tratamiento específico para una indicación particular. El creciente número de enfermedades huérfanas ha aumentado la demanda de productos biológicos y fármacos, lo que posteriormente ha impulsado el crecimiento de los medicamentos personalizados. En 2019, la FDA aprobó ~12 medicamentos personalizados para abordar las causas fundamentales de la enfermedad e integrar aún más la medicina de precisión con la atención clínica. Además, los crecientes esfuerzos del gobierno están fortaleciendo las actividades de investigación de la medicina personalizada. Por ejemplo, en febrero de 2020, el Instituto Nacional de Investigación del Genoma Humano (NHGRI) anunció el establecimiento de un nuevo programa de medicina de precisión y genómica. Este programa se centra en la innovación de herramientas genómicas e informáticas para un mejor diagnóstico y tratamiento de enfermedades. Los medicamentos personalizados aprovechan los avances en genética y bioinformática para dirigirse a poblaciones específicas de pacientes y tratar enfermedades que antes no tenían tratamiento. La medicina personalizada utiliza técnicas de bioprocesamiento para desarrollar terapias personalizadas. Desde el aislamiento de células específicas hasta el desarrollo de tratamientos específicos para cada paciente, los pasos de bioprocesamiento son esenciales para producir tratamientos adaptados a cada paciente. Por lo tanto, se prevé que la creciente demanda de medicina personalizada ofrezca importantes oportunidades de crecimiento a los actores que operan en el mercado de bioprocesamiento durante el período de pronóstico.
Descripción general del mercado de bioprocesamiento de Asia Pacífico
El mercado de bioprocesamiento de Asia Pacífico está segmentado en China, Japón, India, Corea del Sur, Australia y el resto de Asia Pacífico. El crecimiento del mercado en estos países se atribuye a la creciente prevalencia de enfermedades crónicas y políticas de reembolso favorables. Además, se espera que las estrategias de expansión y lanzamiento de productos implementadas por los actores del mercado contribuyan al crecimiento del mercado de tecnología de bioprocesos en la región. China representó la mayor participación del mercado en 2023, y se espera que India registre una CAGR significativa en el mercado durante el período de pronóstico. La industria biofarmacéutica en China está experimentando un cambio tremendo, evolucionando de un panorama centrado en genéricos a un próspero centro de innovación. Además, el progreso en la industrialización y la aplicación de nuevos medicamentos, dispositivos médicos de alta gama y técnicas contribuyen al crecimiento del mercado de bioprocesamiento en China. Por lo tanto, un número cada vez mayor de centros de investigación, el aumento de la financiación gubernamental y las constantes iniciativas adoptadas por los actores del mercado para la expansión geográfica impulsan el crecimiento del mercado de bioprocesamiento en Asia Pacífico.
Ingresos y pronóstico del mercado de bioprocesamiento de Asia Pacífico hasta 2031 (millones de dólares estadounidenses)
Segmentación del mercado de bioprocesamiento de Asia Pacífico
El mercado de bioprocesamiento de Asia Pacífico se clasifica en producto, escala de operación, proceso, aplicación, usuario final y país.
Según el producto, el mercado de bioprocesamiento de Asia Pacífico se bifurca en instrumentos y consumibles y accesorios. El segmento de instrumentos tuvo una mayor participación de mercado en 2023. Además, el segmento de instrumentos está subsegmentado en dispositivos de filtración, biorreactores, sistemas de cromatografía, centrífugas, dispositivos de secado y otros. Además, el subsegmento de biorreactores se clasifica en escala piloto, escala completa y escala de laboratorio. Además, el subsegmento de sistemas de cromatografía se segmenta en cromatografía líquida, cromatografía de gases y otros. Además, el segmento de consumibles y accesorios se subdivide en reactivos, medios de cultivo celular, resinas de cromatografía y otros.
En términos de escala de operación, el mercado de bioprocesamiento de Asia Pacífico se bifurca en operaciones comerciales y operaciones clínicas. El segmento de operaciones comerciales tuvo una mayor participación de mercado en 2023.
Por proceso, el mercado de bioprocesamiento de Asia Pacífico se bifurca en bioproceso descendente y bioproceso ascendente. El segmento de bioproceso descendente tuvo una mayor participación de mercado en 2023.
Según la aplicación, el mercado de bioprocesamiento de Asia Pacífico se clasifica en anticuerpos monoclonales, vacunas, proteínas recombinantes, terapia celular y génica, y otros. El segmento de anticuerpos monoclonales tuvo la mayor participación de mercado en 2023.
En términos de usuario final, el mercado de bioprocesamiento de Asia Pacífico se clasifica en empresas biofarmacéuticas, organizaciones de fabricación por contrato y otras. El segmento de empresas biofarmacéuticas tuvo la mayor participación de mercado en 2023.
Por país, el mercado de bioprocesamiento de Asia Pacífico está segmentado en China, India, Japón, Corea del Sur, Australia y el resto de Asia Pacífico. China dominó la participación de mercado de bioprocesamiento de Asia Pacífico en 2023.
Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc y Cytiva US LLC. son algunas de las empresas líderes que operan en el mercado de bioprocesamiento de Asia Pacífico.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Bioprocessing Market Landscape
4.1 Ecosystem Analysis
4.1.1 List of Vendors in the Value Chain
5. Asia Pacific Bioprocessing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Biopharmaceutical Industry
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.3 Market Opportunities
5.3.1 Proliferating Demand for Personalized Medicine
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact of Drivers and Restraints:
6. Bioprocessing Market - Asia Pacific Analysis
6.1 Asia Pacific Bioprocessing Market Overview
6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031
7. Asia Pacific Bioprocessing Market Analysis - by Product
7.1 Overview
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
7.3 Consumables & Accessories
7.3.1 Overview
7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
8. Asia Pacific Bioprocessing Market Analysis - by Scale of Operation
8.1 Overview
8.2 Commercial Operations
8.2.1 Overview
8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
8.3.1 Overview
8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9. Asia Pacific Bioprocessing Market Analysis - by Process
9.1 Overview
9.2 Downstream Bioprocess
9.2.1 Overview
9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
9.3.1 Overview
9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10. Asia Pacific Bioprocessing Market Analysis - by Application
10.1 Overview
10.2 Monoclonal Antibodies
10.2.1 Overview
10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
10.3.1 Overview
10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
10.4.1 Overview
10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Cell & Gene Therapy
10.5.1 Overview
10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11. Asia Pacific Bioprocessing Market Analysis - by End User
11.1 Overview
11.2 Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
11.3.1 Overview
11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12. Asia Pacific Bioprocessing Market - Country Analysis
12.1 Asia Pacific
12.1.1 Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
12.1.1.1 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.1.1 Overview
12.1.1.2 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 China: Bioprocessing Market Breakdown, by Product
12.1.1.2.1.1 China: Bioprocessing Market Breakdown, by Instruments
12.1.1.2.1.1.1 China: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.2.1.1.2 China: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.2.2 China: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.2.3 China: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.2.4 China: Bioprocessing Market Breakdown, by Process
12.1.1.2.5 China: Bioprocessing Market Breakdown, by Application
12.1.1.2.6 China: Bioprocessing Market Breakdown, by End User
12.1.1.3 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Overview
12.1.1.4 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 India: Bioprocessing Market Breakdown, by Product
12.1.1.4.1.1 India: Bioprocessing Market Breakdown, by Instruments
12.1.1.4.1.1.1 India: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.4.1.1.2 India: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.4.1.2 India: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.4.2 India: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.4.3 India: Bioprocessing Market Breakdown, by Process
12.1.1.4.4 India: Bioprocessing Market Breakdown, by Application
12.1.1.4.5 India: Bioprocessing Market Breakdown, by End User
12.1.1.5 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.5.1 Overview
12.1.1.6 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.6.1 Japan: Bioprocessing Market Breakdown, by Product
12.1.1.6.1.1 Japan: Bioprocessing Market Breakdown, by Instruments
12.1.1.6.1.1.1 Japan: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.6.1.1.2 Japan: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.6.1.2 Japan: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.6.2 Japan: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.6.3 Japan: Bioprocessing Market Breakdown, by Process
12.1.1.6.4 Japan: Bioprocessing Market Breakdown, by Application
12.1.1.6.5 Japan: Bioprocessing Market Breakdown, by End User
12.1.1.7 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.7.1 Overview
12.1.1.8 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.8.1 South Korea: Bioprocessing Market Breakdown, by Product
12.1.1.8.1.1 South Korea: Bioprocessing Market Breakdown, by Instruments
12.1.1.8.1.1.1 South Korea: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.8.1.1.2 South Korea: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.8.1.2 South Korea: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.8.2 South Korea: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.8.3 South Korea: Bioprocessing Market Breakdown, by Process
12.1.1.8.4 South Korea: Bioprocessing Market Breakdown, by Application
12.1.1.8.5 South Korea: Bioprocessing Market Breakdown, by End User
12.1.1.9 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.9.1 Overview
12.1.1.10 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.10.1 Australia: Bioprocessing Market Breakdown, by Product
12.1.1.10.1.1 Australia: Bioprocessing Market Breakdown, by Instruments
12.1.1.10.1.1.1 Australia: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.10.1.1.2 Australia: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.10.1.2 Australia: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.10.2 Australia: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.10.3 Australia: Bioprocessing Market Breakdown, by Process
12.1.1.10.4 Australia: Bioprocessing Market Breakdown, by Application
12.1.1.10.5 Australia: Bioprocessing Market Breakdown, by End User
12.1.1.11 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.11.1 Overview
12.1.1.12 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.12.1 Rest of APAC: Bioprocessing Market Breakdown, by Product
12.1.1.12.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Instruments
12.1.1.12.1.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.12.1.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.12.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.12.2 Rest of APAC: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.12.3 Rest of APAC: Bioprocessing Market Breakdown, by Process
12.1.1.12.4 Rest of APAC: Bioprocessing Market Breakdown, by Application
12.1.1.12.5 Rest of APAC: Bioprocessing Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Getinge AB
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sartorius AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Corning Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 3M Co
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Eppendorf SE
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Repligen Corp
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Entegris Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Agilent Technologies Inc
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Cytiva US LLC
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
?
List of Tables
Table 1. Asia Pacific Bioprocessing Market Segmentation
Table 2. List of Vendors
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 7. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 8. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 9. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 10. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 11. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 12. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 13. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 14. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 16. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 18. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 19. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 20. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 21. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 22. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 23. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 24. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 25. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 26. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 27. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 29. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 30. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 31. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 32. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 33. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 34. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 35. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 36. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 37. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 38. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 39. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 40. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 41. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 42. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 43. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 44. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 45. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 46. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 47. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 48. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 49. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 50. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 51. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 52. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 53. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 54. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 55. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 56. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 57. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 58. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 59. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 60. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 62. Recent Organic Growth Strategies in the Bioprocessing Market
Table 63. Glossary of Terms, Bioprocessing Market
?
List of Figures
Figure 1. Asia Pacific Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Asia Pacific: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 32. Growth Strategies in the Bioprocessing Market
- Getinge AB
- Thermo Fisher Scientific Inc
- Sartorius AG
- Corning Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- 3M Co
- Eppendorf SE
- Repligen Corp
- Entegris Inc
- Agilent Technologies Inc
- Cytiva US LLC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioprocessing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific bioprocessing market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.